Ipamorelin

Ipamorelin is a synthetic pentapeptide and growth hormone secretagogue that has been studied for its effects on growth hormone release.

Research has examined ipamorelin primarily in relation to growth hormone secretion, the growth hormone secretagogue receptor pathway, and pharmacokinetic and pharmacodynamic responses.

Ipamorelin stimulates growth hormone release through a growth hormone secretagogue receptor (GHS-R) pathway.

Yes. Human research has examined ipamorelin in healthy volunteers, including studies of growth hormone responses and pharmacokinetic characteristics.

Preclinical research found ipamorelin to have relatively selective growth hormone-releasing activity compared with some other growth hormone-releasing peptides. Findings depend on the experimental model and conditions studied.

Where applicable, independent laboratory documentation may provide information about product identity, purity, and other analytical characteristics of a tested batch. Analytical results apply only to the specific sample or batch identified in the applicable laboratory documentation.